Background The incidence of adrenal incidentalomas (AIs) is increasing yearly. The early discovery of AIs is helpful to better manage adrenal diseases, especially subclinical primary aldosteronism, Cushing's syndrome and pheochromocytoma.
Xie et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: